PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today provided an update on its previously announced regulatory/commercial pipeline for its Microcyn-based products as the company’s CEO and founder, Hoji Alimi, presented at the Rodman & Renshaw Global Healthcare Conference, which is taking place May 16-18, 2010 in London.
